Home Tags Toll-like receptors

Tag: toll-like receptors

HPAPI Lab at Abzena. Photo Courtesy: 2019 Abzena.

Addressing the Challenges of Bioconjugate Medicines

The continuing advancements in bioconjugate medicines from delivery of potent cytotoxins to vaccine-, oligonucleotide-, radionuclide-, immunomodulator- and check-point inhibitor-conjugates, can start to address the...

How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...

Antibody-drug Conjugates or ADCs combine the selectivity of antibodies with the efficacy of small molecule drugs, allowing for more precise, targeted, therapeutic applications.Combining the...